At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brains Company expands ...
Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...
GlobalData on MSN
Illumina teases transcriptome profiling tech ahead of 2026 launch
Illumina has unveiled a new spatial technology that is designed to unlock further sequencing capabilities for researchers.
Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...
Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on ...
Banovich's poster, "Characterizing alveolar dysregulation in pulmonary fibrosis using the Illumina spatial technology," will be presented at AGBT. 3D tissue reconstruction:Michal Lipinski, PhD, of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results